Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal Carcinoma
Clinical trial NCT04223024 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04223024
- Sponsor
- Sun Yat-sen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-31
- Primary completion
- 2024-08-31
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.